INSMvsVRTX
Insmed IncvsVertex Pharmaceuticals Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
Insmed Inc
$144.48
-26.63%
Vertex Pharmaceuticals Inc
$435.1
-4.37%
60-day price, rebased to 100
Round-by-round
Valuation upside
-90.50% vs -43.10% to DCF fair value
Balance-sheet strength
Altman Z 9.81 vs 12.39
Fundamental quality
Piotroski 4.00 vs 6.00 (of 9)
Growth + margins
Rule-of-40 -92.80 vs 35.50
60-day momentum
-8.45% vs -7.41% price return
Market-cap liquidity
$35.0B vs $119.2B
Verdict
Across6categories,VRTXtakes the edge with6wins to0. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy onINSMorVRTX
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.